Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 59,000 CTMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 59,000 | n/a |
| Jun 16, 2026 | Vaxcyte, Inc. (PCVX) | Grant/Award | 2,265 | n/a |
| Jun 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 5,778 | n/a |
| Nov 21, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 12,220 | $91.8K |
| Jun 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 7,609 | n/a |
| Jun 16, 2025 | Vaxcyte, Inc. (PCVX) | Grant/Award | 3,041 | n/a |
| Jun 13, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 18, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 10,139 | n/a |
| Jun 10, 2024 | Vaxcyte, Inc. (PCVX) | Grant/Award | 1,550 | n/a |
| Jun 5, 2024 | Vaxcyte, Inc. (PCVX) | Exercise/Conversion | 18,200 | $97.4K |